Are Pregnant Women a Big Market for Pfizer and BioNTech's Vaccine?

Brian Orelli, PhD and Keith Speights, The Motley Fool
·3-min read

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) recently started a clinical trial testing their coronavirus vaccine in pregnant women. While this subset of the market would seem to be a minor addition to the vaccine's potential, Fool.com contributors Brian Orelli and Keith Speights break down the clinical trial's clear benefits for the companies in this video from Motley Fool Live, recorded on Feb. 22. Brian Orelli: Finally, Pfizer and BioNTech had two interesting news events this week.